BARD

VERSES Identifies New Path to AGI and Extends Invitation to OpenAI for Collaboration via Open Letter

Retrieved on: 
Tuesday, December 19, 2023

The open letter, published today in The New York Times, outlines how VERSES is pursuing an alternative approach to AGI using Active Inference, a method pioneered by VERSES’ Chief Scientist, Karl Friston.

Key Points: 
  • The open letter, published today in The New York Times, outlines how VERSES is pursuing an alternative approach to AGI using Active Inference, a method pioneered by VERSES’ Chief Scientist, Karl Friston.
  • The Company expects to share more details and validation tests with partners and the broader community in the coming months.
  • With this framework, VERSES aims to solve probabilistic AI’s tractability problem, allowing users to design and deploy adaptive, real-time, scalable AI.
  • Building on this foundation, our latest research has revealed a promising new path toward this goal.”
    To read the full letter, please visit https://www.verses.ai/open-letter.

KX LAUNCHES KDB.AI EARLY ACCESS PROGRAM: NAVIGATING THE FUTURE OF STATEFUL & REAL-TIME AI APPLICATIONS WITH THE WORLD'S #1 VECTOR DATABASE

Retrieved on: 
Tuesday, August 1, 2023

Leveraging the robust and proven KDB+ engine, independently recognized as the fastest time series vector native database , KDB.AI is revolutionizing AI technology.

Key Points: 
  • Leveraging the robust and proven KDB+ engine, independently recognized as the fastest time series vector native database , KDB.AI is revolutionizing AI technology.
  • Providing the best price to performance and efficiency, KDB.AI overcomes traditional vector database challenges.
  • Seamlessly handling both structured and unstructured data, KDB.AI empowers real-time processing, enabling sliding window search for time-series-based vector search.
  • This Early Access Program offers two-year, non-renewable licenses either by department or on an enterprise-wide basis, both with unlimited usage.

KX LAUNCHES KDB.AI EARLY ACCESS PROGRAM: NAVIGATING THE FUTURE OF STATEFUL & REAL-TIME AI APPLICATIONS WITH THE WORLD'S #1 VECTOR DATABASE

Retrieved on: 
Tuesday, August 1, 2023

Leveraging the robust and proven KDB+ engine, independently recognized as the fastest time series vector native database , KDB.AI is revolutionizing AI technology.

Key Points: 
  • Leveraging the robust and proven KDB+ engine, independently recognized as the fastest time series vector native database , KDB.AI is revolutionizing AI technology.
  • Providing the best price to performance and efficiency, KDB.AI overcomes traditional vector database challenges.
  • Seamlessly handling both structured and unstructured data, KDB.AI empowers real-time processing, enabling sliding window search for time-series-based vector search.
  • This Early Access Program offers two-year, non-renewable licenses either by department or on an enterprise-wide basis, both with unlimited usage.

Emerging Markets Report: The Art of Artificial Intelligence

Retrieved on: 
Monday, May 29, 2023

ORLANDO, Fla., May 29, 2023 (GLOBE NEWSWIRE) -- It will come as no surprise to even the most passive investor that the market is currently in a full-throated infatuation with Artificial Intelligence (A.I.). Titillating news headlines wander the gamut of someday sentient machines running the world to the ever-so-more likely game-changing efficiencies for how companies will operate and lives will be enhanced.

Key Points: 
  • It is no different for the behemoth Artificial Intelligence industry.
  • Along those lines kindly allow us to introduce VERSES AI Inc. (VERS.NE) (OTCQX:VRSSF), a cognitive computing company specializing in next-generation Artificial Intelligence.
  • The Company’s flagship offering, GIA ™, is an Intelligent Agent for anyone powered by KOSM ™, a network operating system enabling distributed intelligence.
  • could be changing the very Art of Artificial Intelligence.

VERSES Announces Technical Breakthrough And Patent Filing for Its Next-Gen AI 

Retrieved on: 
Wednesday, May 24, 2023

VERSES AI Inc.'s new invention is designed to streamline and automate the creation of 'intelligent agents' or digital taskmasters.

Key Points: 
  • VERSES AI Inc.'s new invention is designed to streamline and automate the creation of 'intelligent agents' or digital taskmasters.
  • This patent application reflects the process of this standards-based AI agent generation and forms the basis for VERSES' ongoing advancements in the AI space.
  • "We believe our latest patent filing marks a pivotal moment in the evolution of AI," said Gabriel René CEO of VERSES AI.
  • The patent application is the latest in a new series related to VERSES' recent technological advancements in the AI landscape.

Valbiotis Announces the Large Success of the REVERSE-IT International Multicentric Phase II/III Clinical Study on TOTUM•63: Proven Efficacy on the Main Risk Factor of Developing Type 2 Diabetes

Retrieved on: 
Monday, May 22, 2023

We have provided unequivocal clinical evidence that TOTUM•63 is a promising solution for millions of people worldwide, helping to prevent the progression to type 2 diabetes.

Key Points: 
  • We have provided unequivocal clinical evidence that TOTUM•63 is a promising solution for millions of people worldwide, helping to prevent the progression to type 2 diabetes.
  • Beyond this great achievement, which opens up a new path, it is also a personal satisfaction, after almost 10 years of hard work."
  • This non-drug, plant-based active substance has the potential to significantly impact the management of early impairments of glucose metabolism."
  • The randomized and placebo-controlled REVERSE-IT Phase II/III study included 636 people with impaired glucose metabolism, ranging from prediabetes to untreated type 2 diabetes (early stage).

truData Solutions appoints Google sales leader as Chief Revenue Officer to fuel global growth

Retrieved on: 
Monday, May 1, 2023

SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- California-based truData Solutions, a leading cloud professional services firm, has named Brad Dubé as its Chief Revenue Officer (CRO).

Key Points: 
  • SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- California-based truData Solutions, a leading cloud professional services firm, has named Brad Dubé as its Chief Revenue Officer (CRO).
  • "We are thrilled to have Brad join truData’s Leadership Team as CRO," said Nevvar Hickmet, CEO of truData Solutions.
  • "His expertise will be instrumental in driving our growth and enabling truData to continue providing exceptional value to our clients.
  • "I'm thrilled to join truData and collaborate with our global clients to drive business innovation and better data insights using cloud solutions," said Brad Dubé.

Chatbot Market to Hit $24.58 Billion by 2030: Cognitive Market Research

Retrieved on: 
Monday, March 27, 2023

High integration of chatbot in various industrial verticals:

Key Points: 
  • High integration of chatbot in various industrial verticals:
    Chatbot usage is rising exponentially in both the business sector and the consumer market.
  • Hence, the inability to understand this kind of natural language may hamper the growth of the chatbot market.
  • Thus, outbreak of COVID-19 had a positive impact on the chatbot market.
  • Chatbot Market – Component Outlook (Revenue, USD Billion, 2018 – 2030)
    Chatbot Market – Deployment Outlook (Revenue, USD Billion, 2018 – 2030)
    Chatbot Market – Connectivity Outlook (Revenue, USD Billion, 2018 – 2030)

Chatbot Market to Hit $24.58 Billion by 2030: Cognitive Market Research

Retrieved on: 
Monday, March 27, 2023

High integration of chatbot in various industrial verticals:

Key Points: 
  • High integration of chatbot in various industrial verticals:
    Chatbot usage is rising exponentially in both the business sector and the consumer market.
  • Hence, the inability to understand this kind of natural language may hamper the growth of the chatbot market.
  • Thus, outbreak of COVID-19 had a positive impact on the chatbot market.
  • Chatbot Market – Component Outlook (Revenue, USD Billion, 2018 – 2030)
    Chatbot Market – Deployment Outlook (Revenue, USD Billion, 2018 – 2030)
    Chatbot Market – Connectivity Outlook (Revenue, USD Billion, 2018 – 2030)

Valbiotis Presents Additional Positive Results from the HEART Clinical Study on TOTUM•070 for Hypercholesterolemia

Retrieved on: 
Monday, October 3, 2022

Valbiotis (FR0013254851 ALVAL, PEA/SME eligible)(Paris:ALVAL), a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, presents additional positive results from the Phase II HEART clinical study with TOTUM070 for hypercholesterolemia.

Key Points: 
  • Valbiotis (FR0013254851 ALVAL, PEA/SME eligible)(Paris:ALVAL), a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, presents additional positive results from the Phase II HEART clinical study with TOTUM070 for hypercholesterolemia.
  • The Phase II HEART clinical study was a multi-center, international, randomized, placebo-controlled, double-blind study involving 120 people with untreated mild to moderate LDL hypercholesterolemia.
  • At the hepatic level, the clinical mode of action study, which had previously reported positive results ( press release of March 29, 2022 ), has delivered additional results at the molecular level2.
  • Murielle CAZAUBIEL, Director of Medical, Regulatory and Industrial Affairs and member of the Valbiotis Board of Directors, comments: "The additional clinical efficacy results from the HEART study are excellent for TOTUM070.